Catherine Levene - Dec 1, 2021 Form 4 Insider Report for Meredith Holdings Corp (NONE)

Signature
/s/ Andrew Kane, by Power of Attorney for Catherine Levene
Stock symbol
NONE
Transactions as of
Dec 1, 2021
Transactions value $
$0
Form type
4
Date filed
12/3/2021, 02:06 PM
Previous filing
Nov 12, 2021
Next filing
Nov 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NONE Common Stock ($1 par value) Disposed to Issuer -2.05K -100% 0 Dec 1, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NONE Restricted Stock Units Award +41.9K 41.9K Dec 1, 2021 Common Stock ($1 par value) 41.9K Direct F3, F4, F5
transaction NONE Restricted Stock Units Disposed to Issuer -41.9K -100% 0 Dec 1, 2021 Common Stock ($1 par value) 41.9K Direct F3, F5
transaction NONE Non-Qualified Stock Option (right to buy) Award +4K 4K Dec 1, 2021 Common Stock ($1 par value) 4K $38.08 Direct F4, F6
transaction NONE Non-Qualified Stock Option (right to buy) Disposed to Issuer -4K -100% 0 Dec 1, 2021 Common Stock ($1 par value) 4K $38.08 Direct F6
transaction NONE Non-Qualified Stock Option (right to buy) Award +6.55K 6.55K Dec 1, 2021 Common Stock ($1 par value) 6.55K $26.37 Direct F4, F6
transaction NONE Non-Qualified Stock Option (right to buy) Disposed to Issuer -6.55K -100% 0 Dec 1, 2021 Common Stock ($1 par value) 6.55K $26.37 Direct F6
transaction NONE Non-Qualified Stock Option (right to buy) Award +12K 12K Dec 1, 2021 Common Stock ($1 par value) 12K $10.15 Direct F4, F6
transaction NONE Non-Qualified Stock Option (right to buy) Disposed to Issuer -12K -100% 0 Dec 1, 2021 Common Stock ($1 par value) 12K $10.15 Direct F6
transaction NONE Non-Qualified Stock Option (right to buy) Award +13K 13K Dec 1, 2021 Common Stock ($1 par value) 13K $15.66 Direct F4, F6
transaction NONE Non-Qualified Stock Option (right to buy) Disposed to Issuer -13K -100% 0 Dec 1, 2021 Common Stock ($1 par value) 13K $15.66 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Catherine Levene is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The Reporting Person received these shares in the previously announced spin-off of Meredith Corporation's digital and magazine segments and corporate operations (the "Spin-Off"), described in the issuer's Registration Statement on Form 10 filed with the Securities and Exchange Commission on November 9, 2021 (the "Form 10"). The Spin-Off involved the pro rata distribution of shares of the issuer by Meredith Corporation to its shareholders on a one-for-one basis and the Spin-Off was consummated on December 1, 2021. The Reporting Person's receipt of such shares in the Spin-Off was exempt from reporting pursuant to Rule 16a-9.
F2 In connection with the closing of the previously announced acquisition of the issuer by Dotdash Media Inc. (the "Merger") and as described in the Current Report on Form 8-K filed by Meredith Corporation, which was previously the issuer's parent company, on October 6, 2021 (the "8-K"), each share of Common Stock was exchanged for $42.18 in cash per share.
F3 In connection with the Merger and as described in the 8-K, these awards were canceled in exchange for $42.18 in cash per share.
F4 In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person.
F5 Pursuant to their original terms, the Restricted Stock Units were convertible to Common Stock on a one-for-one basis upon the completion of a three-year vesting period.
F6 In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price.